# Darren Cai

> Darren Cai is a seed investor at Sherpa Healthcare Partners backing Health Care and Therapeutics. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Sherpa Healthcare Partners](https://shizune.co/investors/profile/sherpa-venture-capital)
- Total investments: 2
- Last investment: Feb 2026
- Lead investor: 0%
- Last updated: Aug 2026

Darren Cai is a seed investor at Sherpa Healthcare Partners focused on Health Care and Therapeutics. Darren Cai, Ph.D., Founding Partner of Sherpa Healthcare Partners.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 100% |
| Therapeutics | 1 | 50% |
| Biotechnology | 1 | 50% |
| Medical Device | 1 | 50% |
| Nanotechnology | 1 | 50% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Series A | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Avisi Technologies | Avisi Technologies develops ophthalmic medical devices using nanotechnology to address vision loss associated with glaucoma and related eye conditions. The company designs implantable solutions such as VisiPlate, an aqueous shunt that regulates intraocular fluid through microchannel structures to help manage eye pressure. Its work combinesmaterials science and ophthalmology to create minimally invasive devices intended for long-term function within the eye. | $10.8M | Series A | Feb 25, 2026 |  |
| Fuse Biotherapeutics | Fuse Biotherapeutics is a biotech company developing next-generation immune-modulating therapeutics for patients with cancers. The company's therapeutic approach integrates the multiple steps of an immune response in a rational manner such that potent responses to danger are targeted without sacrificing natural breaks in the system that sparehealthy tissues.Fuse Biotherapeutics was founded in 2021 and is headquartered in Los Angeles, CA. | $9.5M | Seed | Nov 15, 2021 |  |

2 of 2 investments shown.

## Co-investors
- [Accanto Partners](https://shizune.co/investors/profile/accanto-partners) — VC Fund, 1 deal together
- [GC&H Investments](https://shizune.co/investors/profile/gc-h-investments) — VC Fund, 1 deal together
- [Gemseki](https://shizune.co/investors/profile/gemseki) — VC Fund, 1 deal together
- [Golden Seeds](https://shizune.co/investors/profile/golden-seeds) — VC Fund, 1 deal together
- [Good Growth Capital](https://shizune.co/investors/profile/good-growth-capital) — VC Fund, 1 deal together
- [Ivy Venture Group](https://shizune.co/investors/profile/ivy-venture-group) — VC Fund, 1 deal together

## About Sherpa Healthcare Partners

VC Fund · Beijing, China

Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.

5 contacts available at Sherpa Healthcare Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Daqing Cai | founder and Managing partner | https://shizune.co/investors/profile/cai-daqing |
| Darren Cai | Founder & Managing Partner | https://shizune.co/investors/profile/darren-cai |
| He Zhu | Vice President | https://shizune.co/investors/profile/he-zhu |
| Ouyang Xiangyu | Co-Founder & Managing Partner | https://shizune.co/investors/profile/ouyang-xiangyu-b45d |
| Shi Yina | Managing Director | https://shizune.co/investors/profile/shi-yina |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Darren Cai invest in?

Darren Cai invests primarily in Health Care, Therapeutics and Biotechnology startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Darren Cai last invest?

The most recent investment recorded for Darren Cai closed in Feb 2026. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co